Sponsor:
City of Hope Medical Center
Code:
NCT06524973
Conditions
Metastatic Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Telemedicine
Counseling
Best Practice
Questionnaire Administration
Inrweview
Brief summary:
Conditions
Metastatic Pancreatic Adenocarcinoma
Study ID
NCT06524973
Start date
Oct 7, 2024
Status verified date
Nov, 2025
Completion date
May 3, 2027
Anticipated
Primary completion date
May 3, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
136 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Arm A (telehealth self-management coaching sessions)
active comparator: Arm B (standard of care)
Interventions
Telemedicine
Counseling
Best Practice
Questionnaire Administration
Inrweview
Primary outcome measure
Central contacts
Locations
City of Hope at Duarte
Recruiting
Duarte, California, United States, 91010
Sponsor
City of Hope Medical Center
Last update posted
Nov 10, 2025
Last verified
Nov, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by City of Hope Medical Center on 2025-11-10.